PUBLISHER: TechNavio | PRODUCT CODE: 2109359
PUBLISHER: TechNavio | PRODUCT CODE: 2109359
Global Artificial Organs Market 2026-2030
The global artificial organs market is forecasted to grow by USD 17005.3 mn during 2025-2030, accelerating at a CAGR of 9.2% during the forecast period. The report on the global artificial organs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expansion of government funding initiatives, integration of digital intelligence technologies, shift toward wearable medical devices.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 9.1% |
| CAGR | 9.2% |
| Incremental Value | $17005.3 mn |
Technavio's global artificial organs market is segmented as below:
By Usage
- Implantable
- Extracorporeal
By Product
- Artificial heart
- Artificial kidney
- Cochlear implants
- Artificial pancreas
By End-User
- Hospitals and clinics
- Ambulatory surgical centers
- Research and academic institutes
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the rise of wearable artificial kidneys as one of the prime reasons driving the global artificial organs market growth during the next few years. Also, integration of neural interface technologies and expansion of bioprinting scaffold solutions will lead to sizable demand in the market.
The report on the global artificial organs market covers the following areas:
- Global artificial organs market sizing
- Global artificial organs market forecast
- Global artificial organs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global artificial organs market vendors that include Abbott Laboratories, Advanced Bionics AG, B.Braun SE, Baxter International Inc., Berlin Heart GmbH, Cochlear Ltd., Diabeloop SA, Envoy Medical Inc., Fresenius Medical Co. KGaA, Getinge AB, Insulet Corp., LivaNova PLC, MED EL Medical Electronics, Medtronic Plc, Nipro Corp., Oticon Medical AS, Outset Medical Inc., Quanta Dialysis Technologies Ltd., Terumo Corp., Toray Industries Inc.. Also, the global artificial organs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Usage
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Artificial Organs Market 2020 - 2024
- Historic Market Size - Data Table on Global Artificial Organs Market 2020 - 2024 ($ million)
- 5.2 Usage segment analysis 2020 - 2024
- Historic Market Size - Usage Segment 2020 - 2024 ($ million)
- 5.3 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- 5.4 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Artificial Organs Market
- 6.2 Impact of geopolitical conflicts on Global Artificial Organs Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Usage
- 8.1 Market segments
- 8.2 Comparison by Usage
- 8.3 Implantable - Market size and forecast 2025-2030
- 8.4 Extracorporeal - Market size and forecast 2025-2030
- 8.5 Market opportunity by Usage
- Market opportunity by Usage ($ million)
9 Market Segmentation by Product
- 9.1 Market segments
- 9.2 Comparison by Product
- 9.3 Artificial heart - Market size and forecast 2025-2030
- 9.4 Artificial kidney - Market size and forecast 2025-2030
- 9.5 Cochlear implants - Market size and forecast 2025-2030
- 9.6 Artificial pancreas - Market size and forecast 2025-2030
- 9.7 Market opportunity by Product
- Market opportunity by Product ($ million)
10 Market Segmentation by End-user
- 10.1 Market segments
- 10.2 Comparison by End-user
- 10.3 Hospitals and clinics - Market size and forecast 2025-2030
- 10.4 Ambulatory surgical centers - Market size and forecast 2025-2030
- 10.5 Research and academic institutes - Market size and forecast 2025-2030
- 10.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 South Africa - Market size and forecast 2025-2030
- 12.6.7 Colombia - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Expansion of government funding initiatives
- Integration of digital intelligence technologies
- Shift toward wearable medical devices
- 13.2 Market challenges
- Biocompatibility and complex material integration
- Regulatory compliance and clinical validation
- High costs and limited reimbursement frameworks
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Rise of wearable artificial kidneys
- Integration of neural interface technologies
- Expansion of bioprinting scaffold solutions
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 15.5 Advanced Bionics AG
- Advanced Bionics AG - Overview
- Advanced Bionics AG - Product / Service
- Advanced Bionics AG - Key offerings
- SWOT
- 15.6 B.Braun SE
- B.Braun SE - Overview
- B.Braun SE - Product / Service
- B.Braun SE - Key offerings
- SWOT
- 15.7 Baxter International Inc.
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key news
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Segment focus
- SWOT
- 15.8 Berlin Heart GmbH
- Berlin Heart GmbH - Overview
- Berlin Heart GmbH - Product / Service
- Berlin Heart GmbH - Key offerings
- SWOT
- 15.9 Cochlear Ltd.
- Cochlear Ltd. - Overview
- Cochlear Ltd. - Business segments
- Cochlear Ltd. - Key offerings
- Cochlear Ltd. - Segment focus
- SWOT
- 15.10 Fresenius Medical Co. KGaA
- Fresenius Medical Co. KGaA - Overview
- Fresenius Medical Co. KGaA - Business segments
- Fresenius Medical Co. KGaA - Key offerings
- Fresenius Medical Co. KGaA - Segment focus
- SWOT
- 15.11 Getinge AB
- Getinge AB - Overview
- Getinge AB - Business segments
- Getinge AB - Key offerings
- Getinge AB - Segment focus
- SWOT
- 15.12 LivaNova PLC
- LivaNova PLC - Overview
- LivaNova PLC - Business segments
- LivaNova PLC - Key offerings
- LivaNova PLC - Segment focus
- SWOT
- 15.13 MED EL Medical Electronics
- MED EL Medical Electronics - Overview
- MED EL Medical Electronics - Product / Service
- MED EL Medical Electronics - Key offerings
- SWOT
- 15.14 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
- 15.15 Nipro Corp.
- Nipro Corp. - Overview
- Nipro Corp. - Business segments
- Nipro Corp. - Key offerings
- Nipro Corp. - Segment focus
- SWOT
- 15.16 Oticon Medical AS
- Oticon Medical AS - Overview
- Oticon Medical AS - Product / Service
- Oticon Medical AS - Key offerings
- SWOT
- 15.17 Terumo Corp.
- Terumo Corp. - Overview
- Terumo Corp. - Business segments
- Terumo Corp. - Key news
- Terumo Corp. - Key offerings
- Terumo Corp. - Segment focus
- SWOT
- 15.18 Toray Industries Inc.
- Toray Industries Inc. - Overview
- Toray Industries Inc. - Business segments
- Toray Industries Inc. - Key news
- Toray Industries Inc. - Key offerings
- Toray Industries Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
